Lester Leung: The Lancet Highlights TAPIS Trial at ESOC 2026
Lester Leung, Chief of Stroke and Cerebrovascular Diseases at Tufts Medical Center, shared The Lancet’s post on X about a recent article by Anxin Wang, published in The Lancet, adding։
”Challenges concerns about concurrent antiplatelet therapy with intravenous thrombolysis for acute ischemic stroke.”
The Lancet shared a post on X:
”Presented today at ESOC 2026:
Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial.”
Title: Ticagrelor with aspirin dual antiplatelet therapy combined with intravenous thrombolysis in patients with ischaemic stroke in China (TAPIS): a multicentre, double-blind, randomised controlled trial
Authors: Anxin Wang, Xue Xia, Ying Tang, Fan Zhang, Xinsheng Han, Jing Li, Xiaoli Zhang, Jing Wang, Yulin Song, Fengyuan Che, Yuzhang Bei, Yong He, Wenji Jing, Junfang Hao, Jinzhao He, Hongqin Yang, Shu Chen, Wei Wu, Ying Li, Hongguo Dai, Chengyan Yang, Zengqiang Sun, Li Li, Yunchao Chen, Philip M Bath, Guillaume Turc, Yilong Wang
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 7, 2026, 06:57Chandran Nadarajan: Targeted Endovascular Thrombolysis Offers Organ-Saving Benefits in Vascular Occlusions
-
Jun 7, 2026, 05:50Sayan Koley: Lupus Anticoagulant – A Key Marker in Thrombosis Risk Assessment
-
Jun 7, 2026, 05:45Nicolas Hubacz: Watching a Heart Build Its Network
-
Jun 7, 2026, 05:40New Evidence Highlights the Urgent Need for Gender-Inclusive Bleeding Disorders Research – EHC
-
Jun 7, 2026, 03:15Shirley D’Sa: What Comes After BTK Inhibitors in Waldenström Macroglobulinaemia?
-
Jun 6, 2026, 23:30Yazan Abou-Ismail: Insights on A Snail-Derived Potential Anticoagulant with Possibly Improved Bleeding Profile
-
Jun 6, 2026, 18:40Igor Carvalho de Oliveira: The Hidden Genetic Risk Behind Early Heart Attacks and Strokes
-
Jun 6, 2026, 17:39Kalyan Roy: Immunomodulation after Blood Transfusion
-
Jun 6, 2026, 17:37Intissar Haddiya: Can Low-Dose Rivaroxaban Improve Cardiovascular Outcomes in Patients with Advanced CKD?